13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846368
Total reported value
$7.2B
$7.2B
101 檔
15.9%
In Q1 2024, Simplify Asset Management Inc.'s U.S. equity holdings reached a combined market value of $7.2B, distributed across 101 disclosed stock positions.
During Q1 2024, Simplify Asset Management Inc.'s portfolio maintained high stability with no major positional turnover, reflecting a continuous long-term holding approach.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | IVV | Ishares Core S&p 500 ETF | ETF-Large Cap & Growth | 30.96% | -0.08% | +63.60% | |
| 2 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 16.37% | — | +588.53% | |
| 3 | XBI | Ss Spdr S&p Biotech ETF | ETF-Tech | 8.74% | — | — | |
| 4 | AGGH | Simplify Aggregate Bond ETF | ETF-Other | 6.25% | -0.07% | -1.28% | |
| 5 | XOP | Ss Spdr S&p Og Exp & Prod | ETF-Other | 5.57% | — | — | |
| 6 | BUCK | Simplify Treasury Option Inc | ETF-Gov Bonds | 4.74% | -0.06% | +197.34% | |
| 7 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 4.04% | — | -79.89% | |
| 8 | AGG | Ishares Core U.s. Aggregate | ETF-Other | 3.45% | +0.69% | +635.10% | |
| 9 | GLD | Spdr Gold Shares | ETF-Commodities | 2.84% | +0.57% | NEW | |
| 10 | PAGP | Plains Gp Holdings Lp-cl A | Stock-Energy | 1.49% | -0.04% | — | |
| 11 | APLT | Applied Therapeutics Inc | Stock-Other | 1.14% | — | +16.55% | |
| 12 | ISRG | Intuitive Surgical Inc | Stock-Healthcare | 0.77% | -0.04% | +491.70% | |
| 13 | SRPT | Sarepta Therapeutics Inc | Stock-Healthcare | 0.70% | — | +281.71% | |
| 14 | CI | THE Cigna Group | Stock-Healthcare | 0.52% | — | +107.87% | |
| 15 | TCRX | Tscan Therapeutics Inc | Stock-Other | 0.49% | — | — | |
| 16 | ✓ | Stock-Other | 0.40% | — | — | ||
| 17 | PCT | Purecycle Technologies Inc | Stock-Other | 0.39% | +0.20% | +221.43% | |
| 18 | FULC | Fulcrum Therapeutics Inc | Stock-Other | 0.38% | — | +20.01% | |
| 19 | COO | Cooper Cos Inc/the | Stock-Healthcare | 0.38% | — | — | |
| 20 | ALGN | Align Technology Inc | Stock-Healthcare | 0.38% | -0.12% | +379.12% | |
| 21 | MRK | Merck & Co. Inc. | Stock-Healthcare | 0.37% | — | +114.80% | |
| 22 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.37% | +0.01% | +93.81% | |
| 23 | MDGL | Madrigal Pharmaceuticals Inc | Stock-Healthcare | 0.37% | — | +62.96% | |
| 24 | AKRO | Akero Therapeutics Inc | Stock-Other | 0.37% | — | +310.99% | |
| 25 | TSLA | Tesla Inc | Stock-Consumer Disc | 0.35% | — | -39.01% | |
| 26 | PHAT | Phathom Pharmaceuticals Inc | Stock-Other | 0.33% | — | +119.36% | |
| 27 | SWAVUSD | Shockwave Medical Inc | Stock-Other | 0.29% | — | +251.98% | |
| 28 | TMO | Thermo Fisher Scientific Inc | Stock-Healthcare | 0.29% | +0.03% | +68.90% | |
| 29 | RPRX | Royalty Pharma plc | Stock-Healthcare | 0.27% | — | — | |
| 30 | EXK | Exact Sciences CORP | Stock-Materials | 0.26% | — | +612.92% | |
| 31 | BSX | Boston Scientific CORP | Stock-Healthcare | 0.25% | — | +114.72% | |
| 32 | ✓ | Athira Pharma Inc | Stock-Other | 0.24% | — | — | |
| 33 | TUA | Sim St Treas Fut Strat ETF | ETF-Other | 0.24% | -0.42% | -45.89% | |
| 34 | LTPZ | Pimco 15+ Yr US Tips Indx | ETF-Other | 0.24% | — | -73.70% | |
| 35 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.23% | +0.14% | +61.88% | |
| 36 | ABBV | Abbvie Inc | Stock-Healthcare | 0.21% | +0.07% | +114.16% | |
| 37 | CDX | Simplify High Yield ETF | ETF-High Yield | 0.20% | — | -40.10% | |
| 38 | ZBH | Zimmer Biomet Holdings Inc | Stock-Healthcare | 0.20% | +0.01% | — | |
| 39 | CTA | Simplify Managed Futures St | ETF-Other | 0.19% | -0.07% | EXIT | |
| 40 | RNAGBP | Avidity Biosciences Inc | Stock-Other | 0.19% | — | — | |
| 41 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 0.17% | -0.13% | EXIT | |
| 42 | HIGH | Simplify Enhanced Income ETF | ETF-Other | 0.17% | — | -0.12% | |
| 43 | DAWNGBX | Day One Biopharmaceuticals I | Stock-Other | 0.17% | — | — | |
| 44 | AVTR | Avantor Inc | Stock-Healthcare | 0.17% | — | — | |
| 45 | RVTY | Revvity Inc | Stock-Healthcare | 0.16% | — | — | |
| 46 | ELV | Elevance Health Inc | Stock-Healthcare | 0.16% | +0.14% | NEW | |
| 47 | PODD | Insulet CORP | Stock-Healthcare | 0.15% | — | +259.81% | |
| 48 | ARDX | Ardelyx Inc | Stock-Other | 0.15% | — | — | |
| 49 | ✓ | Simplify Exchange Traded Fun | Stock-Other | 0.15% | — | -9.43% | |
| 50 | TSAT | Telesat CORP | Stock-Other | 0.15% | — | — |
According to official SEC Form 13F filings, Simplify Asset Management Inc. reported a total U.S. public equity portfolio value of $7.2B across 101 disclosed positions in Q1 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including IVV, IWM, XBI) accounted for 15.9% of total reported equity market value during Q1 2024.
During Q1 2024, Simplify Asset Management Inc.'s top holdings by market value included IVV (31.0%)、IWM (16.4%)、XBI (8.7%). The largest single position, IVV, represented 31.0% of total portfolio value.
In Q1 2024, Simplify Asset Management Inc. made 0 total portfolio adjustments, initiating 0 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.